|
|
 Previous Article | Table of Contents | Next Article 
Vascular Smooth Muscle Cells Potentiate Plasmin Generation by Both Urokinase and Tissue Plasminogen Activator-Dependent Mechanisms: Evidence for a Specific Tissue-Type Plasminogen Activator Receptor on These Cells
Vincent Ellis and
Simon A. Whawell
From the Thrombosis Research Institute, London, UK.
Plasminogen activators play a role in the response of the vessel wall to injury, presumably by mediating the degradation of extracellular matrix (ECM) by vascular smooth muscle cells (VSMCs) that is necessary for their migration and proliferation. We have therefore investigated the ability of VSMCs to assemble specific cell surface plasminogen-activating systems. Urokinase-type plasminogen activator (uPA) bound to a single class of site on VSMCs (kd, 2 nmol/L), binding of pro-uPA resulted in a large potentiation of plasmin generation and both were competed by antibodies to the uPA receptor (uPAR). Tissue-type plasminogen activator (tPA) also bound to VSMCs as determined by functional assay, with the binding isotherms showing two classes of binding site with apparent kds of 25 and 300 nmol/L. tPA binding to the higher affinity site caused a greater than 90-fold enhancement of the activation of cell bound plasminogen, whereas the lower affinity binding, mediated primarily by the ECM, had little effect on tPA activity. The high-affinity binding of tPA to VSMCs resulted in an eightfold greater potential for plasmin generation than the binding of uPA, with this difference increasing to 15-fold after thrombin stimulation of the cells due to a 1.8-fold increase in tPA binding. These data show a novel specific tPA receptor on VSMCs that may be important for the regulation of plasminogen activation in various vascular pathologies.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2312-2322
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Bezuidenhout, M. Bracher, G. Davison, P. Zilla, and N. Davies
Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis
J. Leukoc. Biol.,
June 1, 2007;
81(6):
1496 - 1503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Pawlak, B. S. S. Rao, J. P. Melchor, S. Chattarji, B. McEwen, and S. Strickland
Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus
PNAS,
December 13, 2005;
102(50):
18201 - 18206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Maupas-Schwalm, C. Robinet, N. Auge, J.-C. Thiers, V. Garcia, J.-P. Cambus, R. Salvayre, and A. Negre-Salvayre
Activation of the {beta}-Catenin/T-Cell-Specific Transcription Factor/Lymphoid Enhancer Factor-1 Pathway by Plasminogen Activators in ECV304 Carcinoma Cells
Cancer Res.,
January 15, 2005;
65(2):
526 - 532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V M Diaz, M Hurtado, T M Thomson, J Reventos, and R Paciucci
Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro
Gut,
July 1, 2004;
53(7):
993 - 1000.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Razzaq, R. Bass, D. J. Vines, F. Werner, S. A. Whawell, and V. Ellis
Functional Regulation of Tissue Plasminogen Activator on the Surface of Vascular Smooth Muscle Cells by the Type-II Transmembrane Protein p63 (CKAP4)
J. Biol. Chem.,
October 24, 2003;
278(43):
42679 - 42685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bass, A.-M. M. Fernandez, and V. Ellis
Maspin Inhibits Cell Migration in the Absence of Protease Inhibitory Activity
J. Biol. Chem.,
November 27, 2002;
277(49):
46845 - 46848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Cipolla, N. Lessov, W. M. Clark, and E. C. Haley Jr
Postischemic Attenuation of Cerebral Artery Reactivity Is Increased in the Presence of Tissue Plasminogen Activator • Editorial Comment
Stroke,
April 1, 2000;
31(4):
940 - 945.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Werner, T. M. Razzaq, and V. Ellis
Tissue Plasminogen Activator Binds to Human Vascular Smooth Muscle Cells by a Novel Mechanism. EVIDENCE FOR A RECIPROCAL LINKAGE BETWEEN INHIBITION OF CATALYTIC ACTIVITY AND CELLULAR BINDING
J. Biol. Chem.,
July 30, 1999;
274(31):
21555 - 21561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Longstaff, R. E. Merton, P. Fabregas, and J. Felez
Characterization of Cell-Associated Plasminogen Activation Catalyzed by Urokinase-Type Plasminogen Activator, but Independent of Urokinase Receptor (uPAR, CD87)
Blood,
June 1, 1999;
93(11):
3839 - 3846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Sinniger, R. E. Merton, P. Fabregas, J. Felez, and C. Longstaff
Regulation of Tissue Plasminogen Activator Activity by Cells. DOMAINS RESPONSIBLE FOR BINDING AND MECHANISM OF STIMULATION
J. Biol. Chem.,
April 30, 1999;
274(18):
12414 - 12422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-L. Bochaton-Piallat, G. Gabbiani, and M. S. Pepper
Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines
Circ. Res.,
June 1, 1998;
82(10):
1086 - 1093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
